Treatment of the Temples: Brazilian Consensus.

IF 2 3区医学 Q2 SURGERY

Aesthetic Plastic Surgery Pub Date : 2024-12-13 DOI:10.1007/s00266-024-04614-w

Gladstone Eustaquio de Lima Faria, Daniel Boro Dos Santos, Aneta Hionia Vassiliadis, Andre Vieira Braz, Eliandre Palermo, Bruna Felix Bravo, Luiz Eduardo Toledo Avelar, Daniel Coimbra, Alessandra Haddad, Mariana Muniz, Ada Trindade de Almeida, Ricardo Frota Boggio

{"title":"Treatment of the Temples: Brazilian Consensus.","authors":"Gladstone Eustaquio de Lima Faria, Daniel Boro Dos Santos, Aneta Hionia Vassiliadis, Andre Vieira Braz, Eliandre Palermo, Bruna Felix Bravo, Luiz Eduardo Toledo Avelar, Daniel Coimbra, Alessandra Haddad, Mariana Muniz, Ada Trindade de Almeida, Ricardo Frota Boggio","doi":"10.1007/s00266-024-04614-w","DOIUrl":null,"url":null,"abstract":"Introduction: The temporal region is emblematic and challenging due to its structural and volumetric changes during aging, which significantly affect facial aesthetics. Despite the importance of addressing temporal aging, many injectors hesitate due to the region's anatomical complexity and risk of complications. This consensus aimed to provide expert guidance on the safest and most effective treatment strategies for the temple.Methodology: Twelve Brazilian dermatologists and plastic surgeons with expertise in cosmiatry participated in a survey of 54 objective and one open-ended question to identify best practices. The results were analyzed for consensus, with agreement categorized as a simple majority (50-75%), consensus (> 75%), or strong consensus (> 95%).Results: Participants agreed that volumization (100%), lifting (90%), and restructuring (82%) are essential for temporal rejuvenation. Hyaluronic acid (HA) was the preferred product for volumization and structuring, with the subcutaneous plane identified as the best option for both. There was no consensus on the product for lifting, though 45.5% favored poly-L-lactic acid (PLLA). Biostimulants such as PLLA and calcium hydroxyapatite were commonly used, with specific dilution strategies. Complications reported included hematomas and nodules, particularly with HA and PLLA.Conclusion: The consensus emphasized the importance of anatomical knowledge and product selection in achieving safe and long-lasting results in temporal rejuvenation. It provided clear recommendations for injection techniques and product choices, advocating for subcutaneous plane treatments for beginners. The findings highlight the need for expert-driven approaches to reduce the risk of complications and optimize patient outcomes in this sensitive region.Level of evidence v: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .","PeriodicalId":7609,"journal":{"name":"Aesthetic Plastic Surgery","volume":" ","pages":""},"PeriodicalIF":2.0000,"publicationDate":"2024-12-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Aesthetic Plastic Surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1007/s00266-024-04614-w","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"SURGERY","Score":null,"Total":0}

引用次数: 0

Abstract

Introduction: The temporal region is emblematic and challenging due to its structural and volumetric changes during aging, which significantly affect facial aesthetics. Despite the importance of addressing temporal aging, many injectors hesitate due to the region's anatomical complexity and risk of complications. This consensus aimed to provide expert guidance on the safest and most effective treatment strategies for the temple.

Methodology: Twelve Brazilian dermatologists and plastic surgeons with expertise in cosmiatry participated in a survey of 54 objective and one open-ended question to identify best practices. The results were analyzed for consensus, with agreement categorized as a simple majority (50-75%), consensus (> 75%), or strong consensus (> 95%).

Results: Participants agreed that volumization (100%), lifting (90%), and restructuring (82%) are essential for temporal rejuvenation. Hyaluronic acid (HA) was the preferred product for volumization and structuring, with the subcutaneous plane identified as the best option for both. There was no consensus on the product for lifting, though 45.5% favored poly-L-lactic acid (PLLA). Biostimulants such as PLLA and calcium hydroxyapatite were commonly used, with specific dilution strategies. Complications reported included hematomas and nodules, particularly with HA and PLLA.

Conclusion: The consensus emphasized the importance of anatomical knowledge and product selection in achieving safe and long-lasting results in temporal rejuvenation. It provided clear recommendations for injection techniques and product choices, advocating for subcutaneous plane treatments for beginners. The findings highlight the need for expert-driven approaches to reduce the risk of complications and optimize patient outcomes in this sensitive region.

Level of evidence v: This journal requires that authors assign a level of evidence to each article. For a full description of these Evidence-Based Medicine ratings, please refer to the Table of Contents or the online Instructions to Authors www.springer.com/00266 .

查看原文本刊更多论文

治疗寺庙：巴西共识。

简介：随着年龄的增长，颞区结构和体积的变化对面部美学产生了重大影响，因此颞区具有象征意义和挑战性。尽管解决颞叶老化的重要性，许多注射剂犹豫，由于该地区的解剖复杂性和并发症的风险。这一共识旨在为太阳穴最安全有效的治疗策略提供专家指导。研究方法：12位巴西皮肤科医生和整形外科医生在美容方面具有专业知识，参与了一项调查，共有54个目标和一个开放式问题，以确定最佳做法。对结果进行一致性分析，将一致性分类为简单多数（50-75%），一致性（> 75%）或强一致性（> 95%）。结果：参与者同意体积（100%），提升（90%）和重建（82%）是颞部年轻化的必要条件。透明质酸（HA）是体积和结构的首选产品，皮下平面被认为是两者的最佳选择。尽管45.5%的人支持聚l -乳酸（PLLA），但对举重产品没有达成共识。生物刺激剂如PLLA和羟基磷灰石钙是常用的，有特定的稀释策略。报告的并发症包括血肿和结节，特别是HA和PLLA。结论：共识强调解剖学知识和产品选择在实现安全和持久的颞部年轻化效果的重要性。它对注射技术和产品选择提供了明确的建议，提倡初学者进行皮下平面治疗。研究结果强调需要专家驱动的方法来降低并发症的风险，并优化患者在这一敏感区域的预后。证据等级v：本刊要求作者为每篇文章指定证据等级。有关这些循证医学评级的完整描述，请参阅目录或在线作者说明www.springer.com/00266。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Aesthetic Plastic Surgery 医学-外科

CiteScore

4.40

自引率

25.00%

发文量

479

审稿时长

3 months

期刊介绍： Aesthetic Plastic Surgery is a publication of the International Society of Aesthetic Plastic Surgery and the official journal of the European Association of Societies of Aesthetic Plastic Surgery (EASAPS), Società Italiana di Chirurgia Plastica Ricostruttiva ed Estetica (SICPRE), Vereinigung der Deutschen Aesthetisch Plastischen Chirurgen (VDAPC), the Romanian Aesthetic Surgery Society (RASS), Asociación Española de Cirugía Estética Plástica (AECEP), La Sociedad Argentina de Cirugía Plástica, Estética y Reparadora (SACPER), the Rhinoplasty Society of Europe (RSE), the Iranian Society of Plastic and Aesthetic Surgeons (ISPAS), the Singapore Association of Plastic Surgeons (SAPS), the Australasian Society of Aesthetic Plastic Surgeons (ASAPS), the Egyptian Society of Plastic and Reconstructive Surgeons (ESPRS), and the Sociedad Chilena de Cirugía Plástica, Reconstructiva y Estética (SCCP). Aesthetic Plastic Surgery provides a forum for original articles advancing the art of aesthetic plastic surgery. Many describe surgical craftsmanship; others deal with complications in surgical procedures and methods by which to treat or avoid them. Coverage includes "second thoughts" on established techniques, which might be abandoned, modified, or improved. Also included are case histories; improvements in surgical instruments, pharmaceuticals, and operating room equipment; and discussions of problems such as the role of psychosocial factors in the doctor-patient and the patient-public interrelationships. Aesthetic Plastic Surgery is covered in Current Contents/Clinical Medicine, SciSearch, Research Alert, Index Medicus-Medline, and Excerpta Medica/Embase.